Find your next paid study

National Institute of Mental Health (NIMH)NCT07764536

Actual pay is set by the research site.

Phase 2

Phase 2 Study of Tovorafenib (DAY101) in Relapsed and Refractory Langerhans Cell Histiocytosis

This phase II trial tests the safety, side effects, best dose and activity of tovorafenib (DAY101) in treating patients with Langerhans cell histiocytosis that…

Recurrent Langerhans Cell HistiocytosisRefractory Langerhans Cell Histiocytosis

National Cancer Institute (NCI)NCT05828069

~$75 – $1,800

Actual pay is set by the research site.

Sleep DisturbanceStressFeeling Anxious

GUT-FEELINGS: Using Citizen Science for Large-Scale Prebiotic Clinical Trials for Mental Wellness in Adults, Wave 1

The goal of this study is to evaluate the effects of different products in participants experiencing feelings of anxiety. The main question it aims to answer i…

Holobiome, Inc.NCT07752823

~$10 – $1,050

Actual pay is set by the research site.

Phase 3

A Phase 3, Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection of 4D-150 in Adults With Macular Neovascularization Secondary to Age-Related Macular Degeneration

This Phase 3 study is evaluating the safety and efficacy of 4D-150 versus aflibercept in participants with neovascular age-related macular degeneration (nAMD).…

Neovascular Age-Related Macular Degeneration (nAMD)

4D Molecular TherapeuticsNCT07064759

~$50 – $2,100

Actual pay is set by the research site.

Tailoring a Telemedicine Hypertension Management Intervention for Black Patients

Current clinic-based hypertension (HTN) management models have several limitations, resulting in episodic care that does not adequately support patients' self-…

Hypertension

Wake Forest University Health SciencesNCT06593119

~$10 – $750

Actual pay is set by the research site.

Phase 2

A Phase 2, Open-label Study of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, as Monotherapy and With Cetuximab, in Patients With Metastatic KRAS G12D-Mutated Pancreatic Cancer (TARGET-D 201)

This study will assess the safety and efficacy of VS-7375 alone and in combination with cetuximab in patients with metastatic KRAS G12D - mutated Pancreatic Ca…

Pancreatic Ductal Adenocarcinoma (PDAC)G12D Mutated KRAS

Verastem, Inc.NCT07644559

~$75 – $2,800

Actual pay is set by the research site.

Phase 2

Randomized Phase II Trial of Pembrolizumab and Radiation vs. Radiation and Concurrent Chemotherapy for High-Grade T1 Bladder Cancer (PARRC Trial)

This phase II trial compares the use of pembrolizumab and radiation therapy to chemotherapy with cisplatin, gemcitabine, 5-fluorouracil or mitomycin-C and radi…

Non-Muscle Invasive Bladder Urothelial CarcinomaRecurrent Non-Muscle Invasive Bladder Urothelial CarcinomaStage I Bladder Cancer AJCC v8

National Cancer Institute (NCI)NCT06770582

~$75 – $1,800

Actual pay is set by the research site.

SMART-r: Substance Monitoring and Active Relapse Tracking Repository

Background: About 1.5 million adults in the US enter alcohol or substance use treatment programs each year. Unfortunately, more than half of patients do not f…

AlcoholismSubstance-Related Disorders

National Institute on Drug Abuse (NIDA)NCT06676059

Actual pay is set by the research site.

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

The objective of this study is to assess the safety and efficacy of Apreo BREATHE system when used to support native airways and release trapped air in the tre…

COPDEmphysema

Apreo Health, Inc.NCT06891755

~$10 – $1,050

Actual pay is set by the research site.

A Natural History of Cardiometabolic Disease Among US Bhutanese: Developing the Bhutanese Community of Central Ohio Health Study to Identify Synergizing Socioenvironmental and Biobehavioral Risk Factors Propagating Health Disparities From a Cross-Sectional Study

Background: As of 2021, almost 45 million people in the United States were foreign-born immigrants. South Asians, including people from Bhutan, are the fastes…

Cardiometabolic Risk FactorsMental Health

National Institute of Environmental Health Sciences (NIEHS)NCT06991751

Actual pay is set by the research site.

The Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults >= 55 Years Old. A Randomized Triple-Masked Controlled Clinical Trial

Background: As people age, the cells in the pancreas that produce insulin begin to release less of this hormone, and levels of blood glucose (sugar) rise. Thi…

Healthy Volunteer

National Institute on Aging (NIA)NCT06274749

Actual pay is set by the research site.

Phase 1

Environment and Alcohol: A Pilot Study

Background: Alcohol use disorder (AUD) is a chronic disease that causes more than 140,000 US deaths each year. AUD treatment often includes therapy and medica…

Alcohol Use Disorder